Navigation Links
FDA Approves Merz Pharmaceuticals' Xeomin® (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
Date:8/2/2010

GREENSBORO, N.C., Aug. 2 /PRNewswire/ -- Merz Pharmaceuticals today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Xeomin® (incobotulinumtoxinA), a botulinum toxin type A for the treatment of adults with cervical dystonia or blepharospasm. According to an epidemiology study conducted in Rochester, Minnesota, the prevalence of focal dystonia, which includes cervical dystonia and blepharospasm, is estimated at 295 per million people in the U.S.

"This is an important regulatory milestone for XEOMIN and is key to establishing our neurology business in the U.S.," said Jack Britts, President and CEO of Merz Pharmaceuticals, LLC.  "We at Merz understand, and are committed to, addressing the complexities of treating and living with these neurological disorders."

The FDA approval of XEOMIN is based on the results of two pivotal U.S. clinical trials involving adult patients diagnosed with either cervical dystonia or blepharospasm. Additionally, active comparator studies conducted in Europe evaluating XEOMIN versus Botox® (onabotulinumtoxinA) were included among the data submitted in support of the registration filing in these conditions.

XEOMIN is the only botulinum toxin that does not require refrigeration prior to reconstitution. Merz believes this may simplify product distribution and storage, and help ensure product integrity at the time of injection. XEOMIN will be available in 50-unit and 100-unit vials allowing dosing flexibility for administration.

About Dystonia

Dystonias are neurological movement disorders
'/>"/>

SOURCE Merz Pharmaceuticals, LLC
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013  Healthcare providers ... enterprise content management (ECM) solution, for ... Information System .  These organizations identified enterprise ... and will use OnBase to optimize their ... (Logo:  http://photos.prnewswire.com/prnh/20090130/65710LOGO  ) ...
(Date:5/22/2013)... 2013  Modern Medical announced today the nationwide ... November 2012 in a test phase, ODM is ... the rising opioid abuse in the workers, compensation ... to protect employees, physicians and employers by reducing ... to provide pain relief for the injured worker.  ...
(Date:5/22/2013)... PRINCETON, New Jersey , 22. Mai ... Unternehmen für Fähigkeitsentwicklung und Beratung, gab heute ... Chris Geraghty , zum ... als 20 Jahre im Industriebereich wo er ... die Nachfolge von Ray Baxter an, der ...
Breaking Medicine Technology:Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 2Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 3Modern Medical Introduces Opioid Abuse Solution to the Workers' Compensation Industry 2Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 2Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 3
... NEW YORK, Nov. 17 Romeo and Juliette ... laser hair removal center in New York City to own ... a leading developer and manufacturer of laser and light-based aesthetic ... Cynosure,s patented MultiPlex sequencing technology, is a highly versatile laser ...
... , , SAN CLEMENTE, Calif., Nov. ... child between the ages of two through 12 are ... this coming winter, according to a survey conducted by ... company pioneering clinical research of natural remedies including Sinupret® ...
Cached Medicine Technology:Romeo and Juliette Laser Hair Removal Is First Center in New York City to Own Cynosure's New Elite MPX(TM) Laser System 2Survey Finds Mothers Take Children's Health Into Their Own Hands 2Survey Finds Mothers Take Children's Health Into Their Own Hands 3Survey Finds Mothers Take Children's Health Into Their Own Hands 4
(Date:5/22/2013)... 22, 2013 Officials with Alliance Commercial ... cicada services are now in full effect due to ... cicada cycle emerges. , “The cicada emerges in ... they will emerge, so we’re now offering services to ... protected during the invasion,” said R. Brett Madden, Esq., ...
(Date:5/22/2013)... 2013 Abadir Associates, a Westchester County ... optimal results, is offering a new technique designed to ... The practice has successfully treated multiple patients over the ... approach is for women who want to do everything ... Dr. Michelle Abadir of Abadir Associates. “It allows ...
(Date:5/22/2013)... News) -- Use of the antidepressant Lexapro appears ... condition, a new study finds. The ... myocardial ischemia." Although people with this condition may ... not receiving adequate blood supply, according to researchers ... N.C. However, the researchers found that people ...
(Date:5/22/2013)... New research from Brigham and Women,s Hospital (BWH) ... an uncommon but deadly lung disease, may be effective ... These findings will be presented at the American Thoracic ... New England Journal of Medicine on May ... print edition., "While this variant of the MUC5B gene ...
(Date:5/22/2013)... The PreDiabetes Center of King of ... Philadelphia Tour de Cure, a premier cycling event that brings ... stopping the spread of diabetes , a chronic disease ... Tour de Cure will take place Saturday, June 1 at ... 30 minutes outside of Philadelphia, between the hours of 7:30 ...
Breaking Medicine News(10 mins):Health News:Alliance Commercial Pest Control, Inc. Now Offering Cicada Protection Services 2Health News:Westchester Dermatologist Abadir Associates Offers New Neck Lift Surgery Alternative 2Health News:Antidepressants May Be Helpful for Some Heart Patients: Study 2Health News:Antidepressants May Be Helpful for Some Heart Patients: Study 3Health News:Genetic marker associated with risk for pulmonary fibrosis 2Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 2Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 3
... Jan. 13 (HealthDay News) -- Couples with similar jobs are ... than those in different lines of work, according to a ... England questioned 291 academic workers whose partners had jobs in ... of job. They also conducted 32 online interviews with academics ...
... HealthDay Reporter , THURSDAY, Jan. 12 (HealthDay News) -- ... States could prevent or delay 885,000 cases of type 2 ... Overall, the program would save $29.8 billion in ... billion investment. Still, the researchers said, it would only take ...
... News) --,Blogging appears to help teens deal with social problems, ... high school students, 124 girls and 37 boys, average age ... They all had difficulty making friends or relating to current ... groups were assigned to blog, one group wrote in a ...
... have tried to visualize smaller and smaller structures to provide ... viruses. Now, researchers at the National Institute of Arthritis ... Institutes of Health, have developed a new way to see ... Their findings are reported in the Jan. 13 issue of ...
... Kathleen Doheny HealthDay Reporter , THURSDAY, Jan. ... studied a possible link between substances called parabens -- ... as deodorant/antiperspirants -- and breast cancer. Investigators have ... food products, can mimic weakly the action of the ...
... 2012) Using two cell surface markers ... lymph node metastases, researchers at Moffitt Cancer Center, ... targeted, fluorescent molecular imaging probes that can non-invasively ... procedure could spare breast cancer patients invasive and ...
Cached Medicine News:Health News:Work-Life Balance Tougher for Couples With Similar Jobs 2Health News:U.S. Diabetes Prevention Program Might Avert 885,000 Cases 2Health News:U.S. Diabetes Prevention Program Might Avert 885,000 Cases 3Health News:Blogging Can Help Calm Anxious Teens: Study 2Health News:NIH scientists identify novel approach to view inner workings of viruses 2Health News:Does Deodorant Ingredient Affect Breast Cancer Risk? 2Health News:Does Deodorant Ingredient Affect Breast Cancer Risk? 3Health News:Researchers find new, noninvasive way to identify lymph node metastasis 2
... The Vision5L Digital ... 5- or 7-lead, ... a signal preview,screen. ... using a compact,flash ...
... The Burdick EK-10 ... one-button,soft touch membrane keypad. ... to make a quick ... is ergonomically,designed with a ...
The Atria 6100 delivers the highest level of clinical performance while incorporating cutting-edge technology to streamline clinic workflow. It offers timely, high-quality, and accurate ECG results c...
... CSV-1000LanC 10% test face is ... uses the Landolt C in ... targets. The targets are presented ... is very useful for evaluating ...
Medicine Products: